APON(SZ:300753)2026-03-09 01:12Group 1: Company Overview - Aipeng Medical focuses on medical devices, particularly in pain management and nasal airway management, while also exploring brain-computer interface innovations [4] - The company has established a joint laboratory with Fudan University to integrate research and clinical applications for ADHD treatment [6] Group 2: Product Development and Market Position - The company has developed a non-invasive ADHD behavior management system that connects data between clinical and home settings, currently in the early stages of commercialization [5] - Aipeng Medical's anesthesia depth monitoring device has a low market penetration in China, with less than 20% of surgical units equipped with such devices [7] - The company's pain pump holds a market share of approximately 23%, leading the market, with expectations to increase as it transitions to insurance coverage [8] Group 3: Future Trends and Market Potential - The brain-computer interface market in China is projected to reach approximately 3.8 billion yuan by the end of 2025, with an annual growth rate of nearly 20% [11] - The company prioritizes non-invasive brain-computer interface commercialization while considering strategic expansions into high-barrier invasive technologies [11]